Software company Geospiza said this week that cancer and AIDS research institute SAIC-Frederick will integrate its genetic-analysis software with SAIC-Frederick's Pacific Biosciences sequencer to help perform cancer research.
Geospiza's GeneSifter Lab Edition software is already compatible with Illumina, Life Technologies' SOLiD, and Helicos sequencing platforms.
SAIC-Frederick, which currently uses the software with those machines, will help make it compatible with Pac Bio's Single Molecule Real Time Sequencing technology.
SAIC-Frederick, a subsidiary of Science Applications International Cooperation and a contractor of the National Cancer Institute, penned the deal as part of NCI's Advanced Technology Partnerships Initiative, which "seeks to reduce the time and cost of developing new cancer treatments," according to a statement.
"Having in place a rapid, third-generation sequencing system is expected to accelerate studies into the genetic basis of cancer and to pave the way for more effective treatments," Geospiza said.